OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. Josh Gottheimer (NJ05) disclosed a purchase $1K–$15K

Rep. Josh Gottheimer (NJ05) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
17 days
Disclosure lag
Traded
Jan 24, 2025
Disclosed
Feb 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 8, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Nov 22, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Nov 25, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Nov 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Dec 6, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  6. Dec 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  7. Dec 12, 2024InsiderDirector purchased ~$147K of JNJ shares in the open market
  8. Dec 12, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  9. Dec 24, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  10. Dec 31, 2024CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  11. Jan 8, 2025Congress · 1 personMembers of Congress: 4 purchases
  12. Jan 16, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  13. Jan 21, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  14. Jan 24, 2025 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

  1. Jan 24, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  2. Feb 7, 2025InsiderCFO sold ~$2M of JNJ shares in the open market
  3. Feb 18, 2025InsiderChair sold ~$63K of JNJ shares in the open market
  4. Feb 24, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  5. Feb 25, 2025InsiderOfficer sold ~$1.16M of JNJ shares in the open market
  6. Feb 28, 2025FDAFDA drug approval: Opsumit
  7. Mar 3, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  8. Mar 4, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  9. Mar 5, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  10. Mar 7, 2025FDARecall: PDS¿PLUS¿VIO¿30IN(75CM)¿USP6-0(M0.7)¿D/A¿C-1¿MP
  11. Mar 7, 2025FDARecall: PROLENE BLU 18IN(45CM) USP6-0(M0.7) S/A P-1 PRM
  12. Mar 7, 2025FDARecall: ETHIBOND EXCEL GRN 36IN(90CM) USP2-0(M3) D/A MH
  13. Mar 7, 2025FDARecall: PDSII¿VIO¿30IN(75CM)¿USP6-0(M0.7)¿D/A¿C-1
  14. Mar 7, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  15. Mar 20, 2025FDAFDA drug approval: Tremfya
  16. Mar 21, 2025FDAFDA drug approval: Prezcobix
  17. Mar 24, 2025CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  18. Mar 28, 2025FDAFDA device clearance: Synthes Graphic Case & Tray System
  19. Mar 31, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  20. Apr 1, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Josh Gottheimer (NJ05)

The full history of Rep. Josh Gottheimer (NJ05) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data